Original article
Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis
Papel de los factores inflamatorios sistémicos en los tumores neuroendocrinos gastroenteropancreáticos (TNE-GEP) tratados con péptidos marcados con radionúclidos (PRRT): de la biología a la teragnosis
E. Abou-Jokh Casasa, N. Martínez-Lagob, M.C. Mallón Araujoa,
, J.M. Cabezas Agrícolac, Z. Nogareda Seoaned, A. Cousillas Castiñeirae, A. Ruibal Morellf, V. Pubul Núñeza
Corresponding author
a Department of Nuclear Medicine, Santiago de Compostela University Hospital, Spain
b Department of Oncology, Complexo Hospitalario Universitario A Coruña, Spain
c Department of Endocrinology, Santiago de Compostela University Hospital, Spain
d Department of Nuclear Medicine, Lucus Augusti University Hospital, Spain
e Department of Oncology, Complejo Hospitalario de Pontevedra, Spain
f Professor Emeritus Ad Honorem USC, Santiago de Compostela University Hospital, Spain
